Document:

Exhibit 10.13

 

LOAN
AGREEMENT

 

This
Loan Agreement (the “Agreement”) is entered into on December 19, 2016 and shall be effective as of August 1,
2016 (the “Effective Date”) by and between (i) Yacov Geva, Passport No.                    ,
residing at                                        ,
London WIU 6QQ, United Kingdom (the “Lender”), and (ii) LG Medical Innovation Ltd., (a company incorporated
under the laws the Cayman Islands residing at c/o Intertrust Corporate Services (Cayman) limited, 190 Elgin Avenue, George Town,
Grand Cayman, KY1-9005, Cayman Islands (the “Borrower”, and together with the Lender, the “Parties”).

 

	WHEREAS,	the Borrower
    has requested that the Lender make available to the Borrower a loan in the aggregate amount of up to US$600,000 (“Loan”
    and the “Loan Amount”, respectively) in order to finance its business activities; and
	 	 
	WHEREAS,	subject to the terms and conditions set forth herein, the Lender
    has agreed to extend the loan to the Lender.

 

NOW,
THEREFORE, in consideration of the mutual promises and covenants set forth herein, the Parties hereby agree as follows:

 

		1.	Loan.

 

		1.1.	Funding.
                                         Each request by the Borrower for withdrawal of a portion of the Loan Amount shall
                                         be made by giving to the Lender a notice (the “Drawdown Request”). Each
                                         portion of the Loan Amount so requested to be withdrawn by the Borrower and which the
                                         Borrower is entitled to receive, shall be advanced by the Lender within three (3) business
                                         days of the Lender receiving Borrower said request, by wire transfer thereof to any of
                                         Borrower’s bank accounts specified in the Drawdown Request.

 

		1.2.	Interest.
                                         The Loan shall bear interest at a rate of Libor + 3% per annum as of the date such portion
                                         of the Loan was actually transferred to the Borrower.

 

		1.3.	Repayment
                                         Date. Subject to Section 2.1 below, the Borrower shall repay the Lender the outstanding
                                         Loan Amount plus all accrued interest (“Total Loan Amount Repayable”)
                                         in two equal installments on June 1, 2017, and September 1, 2017.

 

		1.4.	Prepayment,
                                         Methods of Payment. The Borrower shall have the right to prepay the Total Loan Amount
                                         Repayable, or any part thereof  upon prior notice of 14 days without penalty or cost,
                                         such repayment to be made in United  states Dollars.

 

		1.5.	Payment.
                                         Each payment due from Borrower to Lender under this Agreement shall be made by wire transfer
                                         to Lender’s designated bank account as the Lender may notify the Borrower in writing
                                         from time to time, or through any other payment method mutually agreed by the Parties.

 

     

     

    

 

		2.	Events of Default.

 

		2.1.	The occurrence of any
of the following events shall be deemed an event of default and shall automatically, whether or not a notice was given by the
Lender, make the Loan (and all expenses thereon) immediately due and payable:

 

		2.1.1.	Failure
                                         to Pay. The Borrower shall fail to pay the applicable Total Loan Amount Repayable
                                         to the Lender within 30 days of its due date.

 

		2.1.2.	Involuntary
                                         Bankruptcy. Any case or proceeding shall be commenced or other action be taken against
                                         the Borrower in bankruptcy or seeking reorganization, liquidation, dissolution, winding-up,
                                         arrangement, composition or readjustment of its debts, or any other relief, under any
                                         bankruptcy, insolvency, reorganization, liquidation, dissolution, arrangement, composition,
                                         readjustment of debt or any other similar act or law, of any jurisdiction, domestic or
                                         foreign, now or hereafter existing.

 

		2.1.3.	Receivership.
                                         Any case or proceeding shall be commenced or other action taken against the Borrower
                                         for the appointment of a receiver, custodian or trustee for the Borrower.

 

		2.1.4.	Change
                                         of Control. Change of control of the Borrower not approved by the lender.

 

		3.	Miscellaneous.

 

		3.1.	Notices.
                                         Any communications between the Parties or notices provided herein are to be given by
                                         (i) certified or registered mail, postage prepaid, (ii) electronic mail, (iii) facsimile
                                         or (iv) personal delivery, to such addresses as either Party may indicate to the other
                                         in writing.

 

		3.2.	Successors.
                                         This Agreement shall bind and inure to the benefit of the Parties and their respective
                                         successors and assigns, provided that the Borrower shall not assign this Agreement or
                                         any of the rights or obligations of the Borrower hereunder without the prior written consent
                                         of the Lender.

 

		3.3.	Waiver.
                                         No delay or omission by the Lender to exercise any right under this Agreement shall impair
                                         any such right, nor shall it be construed to be a waiver thereof. No waiver of any single
                                         breach or default under this Agreement shall be deemed a waiver of any other breach
                                         or default. Any waiver, consent or approval under this Agreement must be in writing.

 

		3.4.	Governing
                                         Law. This Agreement and any instrument or agreement required hereunder is governed
                                         by and construed in accordance with the laws of the State of Israel excluding that body
                                         of law pertaining to conflict of law. The Parties unconditionally submit to the non- exclusive
                                         jurisdiction of the competent courts of Tel Aviv- Yaffo and courts of appeal from them
                                         with respect to the breach or interpretation of this Agreement or the enforcement of
                                         any and all rights, duties, liabilities, obligations, powers, and other relations between
                                         the parties arising under this Agreement. The Parties will not object to the exercise
                                         of jurisdiction by those courts on any basis.

 

    - 2 -

     

    

 

		3.5.	Severability. The illegality or unenforceability
of any provision of this Agreement shall not in any way affect or impair or enforceability of the remaining provisions of this
Agreement.

 

		3.6.	Entire Agreement. This Agreement constitutes
the entire agreement between the Parties and supersedes all prior agreements and understandings, oral or written, by and between
any of the Parties with respect to the subject of this Agreement.

 

IN WITNESS WHEREOF, the Parties have executed this Agreement on the Effective
Date by their duly authorized officers:

 

	Yacov Geva	 	LG Medical Innovation Ltd.
	[Lender]	 	[Borrower]
	 	 	 	 
	/s/ Yacov Geva	 	By:	/s/ Kenneth Melani
	 	 	Name:	Kenneth Melani
	 	 	Position:	Chairman

 

    - 3 -Exhibit 10.14

 

AMENDMENT TO LOAN AGREEMENT

 

This AMENDMENT (the “Amendment”)
is made as of this 26 day of February, 2017, by and among Mr. Yacov Geva, Passport No.                   ,
residing at                                    ,
London W1U 6QQ, United Kingdom (the “Lender”), and G Medical Innovations Holdings Limited, a company incorporated
under the laws of the Cayman Islands (former LG Medical Innovation Ltd.), having its registered address at P.O. Box 10008, Willow
House, Cricket Square, Grand Cayman, KY1-1001, Cayman Islands (the “Borrower”, and together with the Lender
the “Parties”). Capitalized terms used but not defined herein shall have the respective meanings ascribed
to them in the Loan Agreement (as defined below):

 

WHEREAS, on December 19, 2016
the Lender and the Borrower entered into that certain Loan Agreement under which the Lender made available to the Borrower a
loan in an aggregate amount of up to US$600,000 (the “Loan Agreement” and the “Loan
Amount”, respectively); and

 

WHEREAS, the Lender and the
Borrower desire to amend certain provisions of the Loan Agreement in the manner set forth below;

 

NOW, THEREFORE, in
consideration of the foregoing and the mutual promises made therein the parties hereto, intending to be legally bound, hereby
agree as follows:

 

1. Amendment. The Language of Section 1.3
to the Loan Agreement shall be amended in its entirety to read the following:

  

“1.3 Repayment Date. Subject to Section 2.1 below, the Borrower
shall repay the Lender the outstanding Loan Amount plus all accrued interest (the “Total Loan Amount Repayable”)
in two equal installments after the commencement of sales of the Company’s products (the “Commencement Date”)
as follows: (i) 3 (three) months following Commencement Date; and (ii) 6 (six) months following the “Commencement Date.”

 

2. No Other Amendments. Except to the
extent amended hereby all of the definitions, terms provision and conditions set forth in the Loan Agreement are hereby
ratified and confirmed and remain in full force and effect. The Loan Agreement and this Agreement shall be read and construed
together as a single instrument.

 

3. Governing Law. This Amendment shall for
all purposes be construed in accordance with and governed by the laws of the State of Israel. The competent courts in the
Tel Aviv-Jaffa district, Israel have exclusive jurisdiction over any dispute or claim arising in connection with or as a
result of this Amendment, to the exclusion of any other jurisdiction or venue.

 

4. Counterparts. This Amendment may be
executed in two or more counterparts and the signatures delivered by facsimile or electronic mail, each of which shall be
deemed an original, with the same effect as if the signatures were upon the same instrument and delivered in person.

 

[Signature Page Follows]

 

     

     

    

 

IN WITNESS WHEREOF,
the undersigned have executed this Amendment as of the date written above.

 

	LENDER:	 	BORROWER:
	 	 	 	 
	Yacov Geva	 	G Medical Innovations Holdings Limited
	 	 	 	 
	/s/ Yacov Geva	 	By:	/s/ Kenneth R. Melani
	 	 	Name:	Kenneth R. Melani
	 	 	Title:	Chairman of the Board

 

 

 

 

[Signature page to the Amendment to the Loan Agreement
– February 2017]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00323-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00323-of-00352.parquet"}]]